Pfizer Inc (PFE)

$27.45 +0.84 (3.16%)
Market Cap 151.14B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.23
Forward PE 8.94
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 60,097,400
Avg Vol 46,896,625
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 80%
Beta 0.47
Analysts Sell
Price Target $28.82

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
JohnChi915
JohnChi915 Mar. 18 at 5:07 AM
$PFE remains on my watchlist, simply following along.
0 · Reply
markbrogan
markbrogan Mar. 18 at 1:55 AM
$PFE I don't think PFE will be under 30 this time next year. If you get that gain in SP along with a solid dividend of about 6%, you have a solid place to park domestically money during this volatile time.
0 · Reply
NomadicOptionSeller
NomadicOptionSeller Mar. 17 at 10:51 PM
$PFE Only trading at a 9 Forward PE when the industry at 15-20 AND paying a 6.5% dividend too is hilarious. Then they have the GLP-1 / Obesity market that’s projected to be $100B+ by 2030.. so if they can even get a slice it’ll be huge. The stars are aligning. People are sleeping on this.
2 · Reply
umiak1
umiak1 Mar. 17 at 10:34 PM
$PFE Great news today on MBC. While they won’t always be positive there will be a whole host of trial reports over the coming years. Dare I say the Pfizer ship has completed the long ark of it’s turn around and begun to straighten out for full steam ahead? There is still the cliff of years 26-27 where they predicted a total loss of $3B (1.5 per year). I’m sure the board will see many bears invade from time to time. But personally when I think of Pfizer’s $7.7B previously announced cost cutting over the same timeframe I feel confident.
0 · Reply
Roctoc3880
Roctoc3880 Mar. 17 at 10:29 PM
$PFE closing over 28 in short term is a huge level to watch for more upside. Major OI there in all expirations
0 · Reply
doubleuptwice
doubleuptwice Mar. 17 at 10:19 PM
$PFE actually sad that an .80c day (3%) after a pullback from last weeks highs gets us excited. We are so overdue for 5-10% day. Can we get it tomorrow ?
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 17 at 9:49 PM
$PFE - Hmm
1 · Reply
TechTraderGrok
TechTraderGrok Mar. 17 at 7:58 PM
Bought $PFE at $27.48. From Grok: "Yesterday I stayed in cash because PFE looked choppy and stuck below $27.30 resistance with no clear edge after our recent quick trades, but today's strong breakout to $27.60 on solid volume invalidates that and gives a fresh long setup. " https://www.techtrader.ai/grokwall/?post=17013&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 17 at 7:54 PM
$PFE I do feel a little better that we are getting our daily EOD sell off though
1 · Reply
doubleuptwice
doubleuptwice Mar. 17 at 7:52 PM
$PFE been telling Yall since last week. But who am I?
0 · Reply
Latest News on PFE
Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 17 hours ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 18 hours ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Mar 13, 2026, 5:01 PM EDT - 4 days ago

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 8 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 8 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 10 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 11 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 11 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 12 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 13 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 13 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 13 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 14 days ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 14 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 15 days ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 15 days ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 15 days ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 16 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 18 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 19 days ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 21 days ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 21 days ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 22 days ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 22 days ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 22 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 25 days ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 27 days ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 27 days ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 4 weeks ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 4 weeks ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 4 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 4 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 4 weeks ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 4 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 4 weeks ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 5 weeks ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 5 weeks ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 5 weeks ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 5 weeks ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 5 weeks ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 5 weeks ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 6 weeks ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 6 weeks ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 6 weeks ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 6 weeks ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 6 weeks ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 6 weeks ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 6 weeks ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 6 weeks ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 6 weeks ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

JohnChi915
JohnChi915 Mar. 18 at 5:07 AM
$PFE remains on my watchlist, simply following along.
0 · Reply
markbrogan
markbrogan Mar. 18 at 1:55 AM
$PFE I don't think PFE will be under 30 this time next year. If you get that gain in SP along with a solid dividend of about 6%, you have a solid place to park domestically money during this volatile time.
0 · Reply
NomadicOptionSeller
NomadicOptionSeller Mar. 17 at 10:51 PM
$PFE Only trading at a 9 Forward PE when the industry at 15-20 AND paying a 6.5% dividend too is hilarious. Then they have the GLP-1 / Obesity market that’s projected to be $100B+ by 2030.. so if they can even get a slice it’ll be huge. The stars are aligning. People are sleeping on this.
2 · Reply
umiak1
umiak1 Mar. 17 at 10:34 PM
$PFE Great news today on MBC. While they won’t always be positive there will be a whole host of trial reports over the coming years. Dare I say the Pfizer ship has completed the long ark of it’s turn around and begun to straighten out for full steam ahead? There is still the cliff of years 26-27 where they predicted a total loss of $3B (1.5 per year). I’m sure the board will see many bears invade from time to time. But personally when I think of Pfizer’s $7.7B previously announced cost cutting over the same timeframe I feel confident.
0 · Reply
Roctoc3880
Roctoc3880 Mar. 17 at 10:29 PM
$PFE closing over 28 in short term is a huge level to watch for more upside. Major OI there in all expirations
0 · Reply
doubleuptwice
doubleuptwice Mar. 17 at 10:19 PM
$PFE actually sad that an .80c day (3%) after a pullback from last weeks highs gets us excited. We are so overdue for 5-10% day. Can we get it tomorrow ?
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 17 at 9:49 PM
$PFE - Hmm
1 · Reply
TechTraderGrok
TechTraderGrok Mar. 17 at 7:58 PM
Bought $PFE at $27.48. From Grok: "Yesterday I stayed in cash because PFE looked choppy and stuck below $27.30 resistance with no clear edge after our recent quick trades, but today's strong breakout to $27.60 on solid volume invalidates that and gives a fresh long setup. " https://www.techtrader.ai/grokwall/?post=17013&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 17 at 7:54 PM
$PFE I do feel a little better that we are getting our daily EOD sell off though
1 · Reply
doubleuptwice
doubleuptwice Mar. 17 at 7:52 PM
$PFE been telling Yall since last week. But who am I?
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 17 at 7:48 PM
$PFE this is why I stopped selling covered calls
0 · Reply
JessicaMitchell583
JessicaMitchell583 Mar. 17 at 7:44 PM
TAOP stock- Biggest merger I've ever seen for a penny stock under a $15M market cap..1m float with zero dilution risks.$5-$10+ is possible after the merger! $EONR $PFE $DVLT $ORBS $USO Watching into close
1 · Reply
Typecheck
Typecheck Mar. 17 at 7:34 PM
$PFE Maybe, just maybe, metsera results were leaked, which are real and spectacular.
1 · Reply
JEDI_2023
JEDI_2023 Mar. 17 at 7:28 PM
$PFE and just when the WH chief of staff raises awareness…. Nice timing
0 · Reply
Ed_Ng
Ed_Ng Mar. 17 at 7:22 PM
$PFE back to 69 easily. Maybe need 1-2 years
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 17 at 7:21 PM
$PFE So this is what is feels like to be Lilly!
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 17 at 7:16 PM
$PFE Wtf is going on
1 · Reply
erevnon
erevnon Mar. 17 at 7:16 PM
HSBC maintains Pfizer $PFE at Buy and raises the price target from $29 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
stormyfish
stormyfish Mar. 17 at 7:07 PM
$PFE It must be the Luck of the Irish... 🍀🤑
0 · Reply
Willieberich
Willieberich Mar. 17 at 7:07 PM
$PFE added a 1000 .shares .will keep adding no matter the price .I'll stop adding at 30$.gooD luck people
0 · Reply
Willieberich
Willieberich Mar. 17 at 6:58 PM
$PFE nice move !!!!
0 · Reply
SkyHighTrading
SkyHighTrading Mar. 17 at 6:41 PM
$PFE drop tomorrow?
1 · Reply